<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "anti-thymocyte globulin (THYMOGLOBULIN) inj VIAL">
<dose><value>1 - 1.5</value>
<value>1.5 - 3</value>
<value>1.5</value>
<value>1 - 2</value>
<value>2</value>
<value>2</value>
<value>3</value>
<value>1.5 - 2</value>
<value>10</value>
<value>3.5</value>
<value>2.5</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>anti-thymocyte globulin (THYMOGLOBULIN) inj VIAL</value>
</drugname><strength><value>25 mg</value>
</strength><frequency><value>DAILY</value>
<value>EVERY OTHER DAY</value>
<value>ONCE</value>
</frequency><instruction><value>Administer DAILY for 4 days prior to transplant.</value>
<value>Administer pre-transplant.</value>
<value>Administer Post-op Day 1.</value>
</instruction><volume></volume><units><value>mg/kg/day</value>
<value>mg/kg</value>
<value>mg/kg/dose</value>
</units><additionalnotes><value>Renal Transplant. Induction: 5 doses, MAXIMUM 150 mg/dose, Maximum cumulative dose 6 mg/kg.</value>
<value>Bone Marrow Transplant</value>
<value>Treatment of Graft-versus-Host disease.</value>
<value>Renal Transplant. Induction for 4 to 5 days post-op.</value>
<value>Treatment of Renal Transplant rejection. 7 to 14 days treatment.</value>
<value>Heart/Lung Transplant. Induction for 5 days post-op, dependent upon baseline platelet count.</value>
<value>Treatment of Heart/Lung transplant rejection. 5 days treatment.</value>
<value>Liver, Intestinal, or Multivisceral Transplant. Induction/pre-conditioning.</value>
<value>Treatment of Liver, Intestinal, or Multivisceral Transplant rejection. 7 to 14 days treatment.</value>
<value>Familial Hemophagocytic Lymphohistiocytosis.</value>
<value>Aplastic Anemia.</value>
<value>Treatment of Renal Transplant rejection. Up to 5 doses, MAXIMUM 150 mg/dose, Maximum cumulative dose 6 mg/kg.</value>
<value>Treatment of Liver Transplant rejection. MAXIMUM 150 mg/dose, Maximum cumulative dose 7 to 12 mg/kg.</value>
<value>Treatment of Graft-versus-Host disease. Treatment: 4 doses.</value>
<value>Aplastic Anemia. Treatment: 5 days.</value>
</additionalnotes><population><value>ADULT</value>
<value>CHILDREN</value>
</population><indicationprn></indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3555</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Immunosuppressive Agents</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>02246805</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>